Dawn McGraw v. HHS - Hepatitis B, Guillain Barré Syndrome (“GBS”) (2017)
Case summary [AI summaries can sometimes make mistakes]
Dawn McGraw filed a petition on May 3, 2012, alleging that a Hepatitis A and/or Hepatitis B vaccination she received on October 12, 2010 caused her to develop Guillain-Barré Syndrome (GBS). The respondent denied that the vaccines caused petitioner's injury.
However, both parties agreed to settle the case through a joint stipulation filed on March 22, 2017. Special Master Mindy Michaels Roth reviewed the stipulation and adopted it as the decision of the Court.
Petitioner was awarded a lump sum of $365,840.40, representing compensation for all damages available under 42 U.S.C. § 300aa-15(a). The public decision does not describe the specific onset of symptoms, clinical details, or any expert testimony presented.
Theory of causation
Petitioner Dawn McGraw alleged that a Hepatitis A and/or Hepatitis B vaccination administered on October 12, 2010, caused her to develop Guillain-Barré Syndrome (GBS). Respondent denied causation. The parties reached a settlement via joint stipulation filed on March 22, 2017. Special Master Mindy Michaels Roth adopted the stipulation, awarding petitioner $365,840.40. The public decision does not detail the specific mechanism of causation, expert testimony, or the breakdown of the award beyond the total lump sum.
Source PDFs
USCOURTS-cofc-1_12-vv-00282